Early and Late Changes of MMP-2 and MMP-9 in Bleomycin-Induced Pulmonary Fibrosis

다국어 초록 (Multilingual Abstract)

Purpose: Matrix metalloproteinases (MMPs) have been implicated in the pathogenesis of pulmonary fibrosis. To understand the role of MMP-2 and MMP-9 in pulmonary fibrosis, we evaluated the sequential dynamic change and different cellular sources of the 2 MMPs along the time course and their differential expression in the bronchoalveolar lavage (BAL) fluid and in the lung parenchyma of the bleomycin-induced pulmonary fibrosis models in rats. Materials and Methods: The level of MMPs in BAL fluid of 54 bleomycin-treated rats was assessed by zymography from 1 to 28 days after intratracheal bleomycin instillation. The level of MMPs in lung parenchyma was evaluated by immunohistochemistry. Results: MMP-2 and MMP-9 were markedly increased in both the BAL fluid and in the lung parenchyma of the bleomycin-treated rats, especially in the early phase with the peak on the 4th day. The levels of both MMPs in the BAL fluid correlated generally well to those in lung parenchyma, although the level of MMP-9 in BAL fluid was higher than MMP-2. In the lung parenchyma, the 2 MMPs, in early stage, were predominantly expressed in the inflammatory cells. In late stage, type II pneumocytes and alveolar epithelial cells at the periphery of the fibrotic foci retained MMP expression, which was more prominent in the cells showing features of cellular injury and/or repair. Conclusion: In bleomycin-induced pulmonary fibrosis, MMP-2 and MMP-9 may play important roles, especially in the early phase. In the late stage, the MMP-2 and MMP-9 may play a role in the process of repair.

참고문헌 (Reference)

1 Segura-Valdez L, "Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD" 117 : 684-694, 2000

2 Broekelmann TJ, "Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis" 6642-6646, 1991

3 Oggionni T, "Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis" 50 : 317-325, 2006

4 Choi KH, "The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia" 121 : 1478-1485, 2002

5 Murphy G, "The matrix metalloproteinases and their inhibitors" 7 : 120-125, 1992

6 White ES, "Thannickal VJ. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis" 201 : 343-354, 2003

7 Smith RE, "TNF and IL-6 mediate MIP-1alpha expression in bleomycin- induced lung injury" 64 : 528-536, 1998

8 Yang K, "TGF-betal transgenic mouse model of thoracic irradiation: modulation of MMP-2 and MMP-9 in the lung tissue" 26 : 301-304, 2006

9 Kasai H, "TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)" 6 : 56-, 2005

10 Bonniaud P, "TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis" 175 : 5390-5395, 2005

11 Beeh KM, "Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease- 1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects" 97 : 634-639, 2003

12 Oikonomou N, "Soluble TNF mediates the transition from pulmonary inflammation to fibrosis" 1 : e108-, 2006

13 Corbel M, "Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury" 33 : 749-754, 2000

14 Kunugi S, "Role of MMP-2 in alveolar epithelial cell repair after bleomycin administration in rabbits" 81 : 1309-1318, 2001

15 Kelly M, "Re-evaluation of fibrogenic cytokines in lung fibrosis" 9 : 39-49, 2003

16 Crouch E, "Pathobiology of pulmonary fibrosis" 259 : L159-L184, 1990

17 Lemjabbar H, "Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment" 20 : 903-913, 1999

18 Nettesheim P, "Morphogenesis of alveolar bronchiolization" 26 : 210-219, 1972

19 Ohnishi K, "Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema" 78 : 1077-1087, 1998

20 Fukuda Y, "Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases" 78 : 687-698, 1998

21 Kunkel SL, "Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung" 17 : 17-23, 1991

22 Corbel M, "Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat" 193 : 538-545, 2001

23 Chung KF, "Inflammatory mediators in chronic obstructive pulmonary disease" 4 : 619-625, 2005

24 John M, "Increased production of matrix metalloproteinase-2 in alveolar macrophages and regulation by interleukin-10 in patients with acute pulmonary sarcoidosis" 28 : 55-68, 2002

25 Hayashi T, "Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis" 149 : 1241-1256, 1996

26 Yaguchi T, "Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis" 48 : 954-963, 1998

27 Lanchou J, "Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients" 31 : 536-542, 2003

28 Selman M, "Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy" 134 : 136-151, 2001

29 Pardo A, "Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications" 153 : 833-844, 1998

30 Betsuyaku T, "Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin" 157 : 525-535, 2000

31 Eickelberg O, "Extracellular matrix deposition by primary human lung fibroblasts in response to TGFbeta1 and TGF-beta3" 276 : L814-L824, 1999

32 Sasaki M, "Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha" 9 : 155-160, 2000

33 Bergeron A, "Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10" 22 : 69-76, 2003

34 Strieter RM, "Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis" 165 : 1206-1207, 2002

35 Laemmli UK, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4" 227 : 680-685, 1970

36 Suga M, "Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias" 162 : 1949-1956, 2000

37 Yao PM, "Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells" 18 : 813-822, 1998

38 Kawamoto M, "Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats" 40 : 227-238, 1990

39 Gabazza EC, "Bleomycin-induced lung fibrosis: the authors should have used another method to induce pulmonary lesions resembling human idiopathic pulmonary fibrosis" 165 : 845-846, 2002

40 Allred DC, "Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer" 85 : 200-206, 1993

41 Kuhn C 3rd, "An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis" 140 : 1693-1703, 1989

42 Denholm EM, "Alveolar macrophage secretion of a 92-kDa gelatinase in response to bleomycin" 265 : L581-L585, 1993

43 Legrand C, "Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling" 146 : 517-529, 1999

44 Bonniaud P, "Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis" 168 : 770-778, 2003

45 Ferry G, "Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury" 402 : 111-115, 1997

46 Gauldie J, "A new direction in the pathogenesis of idiopathic pulmonary fibrosis?" 3 : 1-, 2002